16-Nov-2021 By Rachel Arthur
CRISPR Therapeutics and ViaCyte, Inc. have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D)....
Nordic Life Science Days
27-Sep-2019 By Vassia Barba
NextCell’s development platform enables the selection of specific stem cells in order to create a treatment with various potential indications.
28-Aug-2018 By Melissa Fassbender
The joint drug discovery project announced yesterday will combine Centogene’s genetic testing service offerings with Evotec's iPSC platform and drug discovery capabilities.
30-Aug-2016 By Dan Stanton
A device that isolates and sprays a patient’s own stem cells onto serious burns could have significant implications in the organ regeneration industry, says developer RenovaCare.
29-Jun-2016 By Melissa Fassbender
Researchers supported by the National Institutes of Health (NIH) have developed a clinical-grade stem cell line, which will help accelerate early-stage clinical research.
New hires at Merck Serono, Amgen, Takeda and Fate Therapeutics this week. It's in-Pharmatechnologist.com's people column.
Stemedica & AnC form stem cell production joint venture
14-Oct-2010 By Nick Taylor
Stemedica and AnC Bio have formed a joint venture to manufacture stem cells for the treatment of ischemic stroke and other degenerative disorders.
Cali OKs Stemedica to manufacture stem cells for trials
03-Sep-2009 By Gareth Macdonald
Stemedica Cell Technologies’ new license to make stem cells for trials positions the firm as a “valuable resource for front line researchers,” according to VP of business development Dave McGuigan.
First green light for stem cell clinical trials
27-Jan-2009 By Phil Taylor
The US Food and Drug Administration (FDA) gave the go-ahead to the first clinical trials of a stem cell-based therapy late last week, in a major boost to the development of the technology.
Deal for development of insulin-producing cells
29-Oct-2008 By Nick Taylor
The development of insulin-producing cells from human stem cells is to be advanced by a collaborative research agreement involving Novo Nordisk.
ReInnervate the difference for stem cells
08-Sep-2008 By Dr Matt Wilkinson
UK researchers have developed two synthetic molecules that coax stem cells to differentiate into either neurons or epithelial cells for use in drug discovery applications.
New research takes the bite out of the stem cell debate
29-Aug-2008 By Dr Matt Wilkinson
Japanese scientists have derived ‘embryonic’ stem cells from tissue taken from discarded human wisdom teeth, potentially bypassing the ethical dilemma of taking them from embryos.
New well plate differentiates itself from the crowd
22-Aug-2008 By Dr Matt Wilkinson
Stemcell Technologies has launched a new well plate that promises to enable researchers to improve the process of differentiating stem cells into mature cell lines.
Healthy skin cells morphed into cancer stem cells
10-Apr-2008 By David Robson
Researchers have genetically engineered normal skin cells into
cancer stem cells - a previously elusive type of stem cell that are
thought to drive cancer.
Stem cells 'cleaned up' with antibody terminators
10-Apr-2008 By Wai Lang Chu
Scientists believe they may have found the key to eliminating stem
cells that pose a cancerous threat when it comes to differentiation
during the cell's life cycle.
Scientists challenge amniotic stem cell research
11-Mar-2008 By David Robson
It had been touted as providing a less controversial alternative to
embryonic stem cells, but Italian researchers have thrown into
question the validity of research claiming to demonstrate the use
of amniotic stem cells to generate...
No embryo required: human stem cells from the skin
21-Nov-2007 By Mike Nagle
A startling breakthrough has allowed scientists to create human
stem cells from just reprogrammed skin cells, with no embryo and
thus, perhaps no ethical dilemma.
Stem cell breakthrough avoids the embryo controversy
15-Nov-2007 By Dr Matt Wilkinson
US researchers have developed a way of creating primate embryonic
stem cells that avoids the need to use fertilised embryos,
potentially leading to more ethical ways of curing degenerative
Neural stem cell drug delivery is encapsulating
05-Nov-2007 By Katrtina Megget
Inherited genetic disorders could be treated with a new stem
cell-based drug delivery therapy through the use of microcapsules.
Microfluidic stimulation of cells in culture
24-Oct-2007 By Dr Matt Wilkinson
US researchers have developed a fully automated microfluidic cell
culture system that can control signalling agents in the
extracellular media while maintaining cell viability for weeks.
Big pharma enters stem cell domain to address safety, attrition
04-Oct-2007 By Mike Nagle
Three of the world's biggest pharmaceutical companies have signed a
landmark deal with the UK government that will see them use stem
cell technology to road-test the safety of new compounds.
Contract manufacturing news in brief
23-Aug-2007 By Kirsty Barnes
Patheon, Lifeline Cell Technology and SRI International have all
recently announced new contract manufacturing deals of late.
Invitrogen takes the stress out of stem cell 'passaging'
13-Aug-2007 By Dr Matt Wilkinson
The launch of Invitrogen's Stempro EZPassage should substantially
reduce the time and stress involved in dividing up cultures of
human embryonic stem cell (hESC) colonies.
Improved culture media could advance stem cell research
12-Jul-2007 By Phil Taylor
Medicult, a Danish company best known for supplying products for
use in fertility clinics, has developed a protein-free cell culture
medium that could cut out problems associated with current media.
'Theory of Everything' for stem cells
20-Jun-2007 By Mike Nagle
A team of Canadian scientists have identified which genes help
decide a stem cell's fate; a discovery that one day could lead to
drugs that invoke their regenerative power.
Cancer stem cells therapies in clinical trials
14-May-2007 By Mike Nagle
Specific stem cells are thought to be the origin of many, if not
all, cancers and although there are several drugs in clinical
trials, only small companies are currently conducting research in
16-Apr-2007 By Dr Matt Wilkinson
A new study has shown that certain human bone marrow stem cells can differentiate into sperm stem cells - potentially leading to a revolution in fertility therapy.
Precancerous stem cells identified
14-Mar-2007 By Dr Matt Wilkinson
The discovery of precancerous stem cells may yield valuable new
drug targets for use in the fight against cancer.
Stem cells have multiple brain benefits
12-Mar-2007 By Mike Nagle
Not only can stem cells replace diseased brain tissue, but they can
also form functional nerve cells that transmit electrical impulses,
according to scientists working on rare brain disorders.
Cellartis channels Scottish expertise in stem cells
22-Jan-2007 By Mike Nagle
Cellartis has begun a new research programme in Scotland as part of
a £9.5m (€14.5m) programme by ITI Life Sciences to develop the
world's first automated process to produce high-quality human stem
Stem cell device could have role in cancer treatment
10-Jan-2007 By Dr Matt Wilkinson
Researchers at the University of Rochester and StemCapture have
unveiled a new device technology that makes it possible to harvest
stem cells from the blood, bypassing the controversial use of stem
cells sourced from embryos.
Ethical Stem Cell Source
08-Jan-2007 By Mike Nagle
Scientists have discovered stem cells in the amniotic fluid that
surrounds the foetus in pregnant women, bypassing ethical concerns
over the source of the versatile cells.
PACS stem cell purifier
18-Dec-2006 By Dr Matt Wilkinson
New stem cell purification technology allows fast and accurate
Report predicts new age of regenerative medicine
18-Oct-2005 By Wai Lang Chu
According to a new report, worldwide revenues for cell and cytokine
therapies in regenerative medicine are set to reach $20.7 billion
(€17.3 billion) in 2010 in a sector that provides a viable
alternative to using drugs or other therapies.
Stem cells to have diagnostic tool application
03-Oct-2005 By Wai Lang Chu
Stem cells have the potential to become an effective diagnostic
tool singling out those susceptible of atherosclerosis, say
researchers. These cells could also help to predict regeneration of
heart cells following a heart attack.
UK to clone embryos to help diabetics
Scientists in the UK are tipped to be given approval this week to
create cloned human embryos to harvest stem cells to treat diabetes
patients and with the possibility of treating other diseases such
as Parkinson's and Alzheimer's.
Korean scientists claim first in human cloning study
Scientists in South Korea have isolated stem cells from a cloned
human embryo for the first time, bringing the use of cell- or
tissuse-based therapies for treating disease a step nearer. But the
work has also re-ignited the controversy...